| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |